Skip to content

Coping Intervention After Embryo Transfer

Study of the Effectiveness of a Coping Selfhelp Intervention for Women in the Waiting Period After an Embryo Transfer During an IVF/ISCI Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01701011
Enrollment
377
Registered
2012-10-04
Start date
2010-10-31
Completion date
2013-02-28
Last updated
2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

coping, intervention, waiting-period

Brief summary

Background of the study: Undergoing an IVF or ICSI treatment is an emotional and physical burden for both the woman and her partner. Most stressful for the couple is waiting for the result of the treatment, the period after the embryotransfer until the pregnancy test or menstruation and an unsuccessful treatment. Symptoms of anxiety and depression have been identified in couples during the waitingperiod after an embryotransfer. For this waitingperiod a short selfhelp copingintervention has been developed based on the stress theory of Lazarus for women to use at home. Goal of the instrument is to stimulate the copingstyle positive reappraisal. Research has demonstrated that using this copingstyle can have a positive impact in health related circumstances.

Detailed description

Objective of the study: To investigate if a short copingintervention reduces anxiety in patients undergoing an IVF or ICSI treatment in the UMCU during the waitingperiod after an embryotransfer. Study design: In this research a randomised controlled trial (RCT) will be used for three groups. The choice for three groups has been based on earlier research with a daily record keeping (DRK). The DRK is a daily measurement for emotions, copingstyle and physical complaints. Previous research with the DRK showed an increase of anxiety. More research must be done of the impact of the DRK. Group 1: Positive Reappraisal Coping Intervention (PRCI) & DRK & questionnaires Group 2: DRK & questionnaires Group 3: Standard care & questionnaires Study population: Patients undergoing an IVF or ICSI treatment in the UMCU. Intervention (if applicable): A selfhelp coping intervention Primary study parameters/outcome of the study: Anxiety Secondary study parameters/outcome of the study (if applicable): Risk of emotional problems copingstyle depression vital pregnancy quality of life Nature and extent of the burden and risks associated with participation, benefit and group relatedness (if applicable): Using the coping intervention may reduce anxiety for the patient. The use of this instrument is not a burden for patients. The burden for patients is to complete questionnaires before, during and six weeks after the embryotransfer. Partners are asked to fill in a questionnaire at three times.

Interventions

BEHAVIORALCoping intervention

Positive reappraisal coping intervention

Sponsors

Bart CJM Fauser
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Patient in IVF/ICSI treatment

Exclusion criteria

* Patient who do not speak the dutch language

Design outcomes

Primary

MeasureTime frameDescription
AnxietyT1 during the first week of the stimulation phase, T2 on the 10th day after embryo transfer, T3 six weeks after embryo transferThe Hospital Anxiety and Depression Scale (HADS) was used to measure general anxiety and depression (Zigmond and Snaith, 1983). TheHADSconsists of 14 items (7 items for each subscale) that are rated on a 4-point Likert scale. The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0 to 21). Scores on each scale can be interpreted in ranges: normal (0-7), mild (8-10), moderate (11-14) and severe (15-21) anxiety and depression.

Secondary

MeasureTime frameDescription
DepressionT1 during the first week of the stimulation phase, T2 on the 10th day after embryo transfer, T3 six weeks after embryo transferThe Hospital Anxiety and Depression Scale (HADS) was used to measure general anxiety and depression (Zigmond and Snaith, 1983). TheHADSconsists of 14 items (7 items for each subscale) that are rated on a 4-point Likert scale. The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0 to 21). Scores on each scale can be interpreted in ranges: normal (0-7), mild (8-10), moderate (11-14) and severe (15-21) anxiety and depression.

Countries

Netherlands

Participant flow

Recruitment details

In the 20 months of recruitment, between October 2010 and June 2012, 1445 letters were sent to women with an invitation to the trial.

Pre-assignment details

Of the 565 women who replied via a letter or email, 188 (33%) were not eligible. The remaining 377 women were randomised and the 349 who had an embryo to transfer (n=119 PRCI-monitoring, n=117 monitoring-control, n=113 routine care control)

Participants by arm

ArmCount
PRCI-monitoring Group
Coping intervention, Daily Record Keeping, Questionnaires Coping intervention, Daily Record Keeping, Questionnaires :
127
Monitoring-control Group
DRK and Questionnaires Coping intervention, Daily Record Keeping, Questionnaires :
126
Routine Care Control Group
Questionnaires Coping intervention, Daily Record Keeping, Questionnaires :
124
Total377

Baseline characteristics

CharacteristicPRCI-monitoring GroupMonitoring-control GroupRoutine Care Control GroupTotal
Age, Continuous34.9 years
STANDARD_DEVIATION 4.7
34.6 years
STANDARD_DEVIATION 4.7
34.8 years
STANDARD_DEVIATION 5
34.8 years
STANDARD_DEVIATION 4.8
Region of Enrollment
Netherlands
127 participants126 participants124 participants377 participants
Sex: Female, Male
Female
127 Participants126 Participants124 Participants377 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 1270 / 1260 / 124
serious
Total, serious adverse events
0 / 1270 / 1260 / 124

Outcome results

Primary

Anxiety

The Hospital Anxiety and Depression Scale (HADS) was used to measure general anxiety and depression (Zigmond and Snaith, 1983). TheHADSconsists of 14 items (7 items for each subscale) that are rated on a 4-point Likert scale. The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0 to 21). Scores on each scale can be interpreted in ranges: normal (0-7), mild (8-10), moderate (11-14) and severe (15-21) anxiety and depression.

Time frame: T1 during the first week of the stimulation phase, T2 on the 10th day after embryo transfer, T3 six weeks after embryo transfer

Population: Only in women with embryo transfer

ArmMeasureGroupValue (MEAN)Dispersion
PRCI-monitoring GroupAnxietyTime 27.302 units on a scaleStandard Error 0.269
PRCI-monitoring GroupAnxietyTime 16.279 units on a scaleStandard Error 0.242
PRCI-monitoring GroupAnxietyTime 35.798 units on a scaleStandard Error 0.279
Monitoring-control GroupAnxietyTime 27.526 units on a scaleStandard Error 0.249
Monitoring-control GroupAnxietyTime 16.223 units on a scaleStandard Error 0.243
Monitoring-control GroupAnxietyTime 35.571 units on a scaleStandard Error 0.262
Routine Care Control GroupAnxietyTime 16.095 units on a scaleStandard Error 0.251
Routine Care Control GroupAnxietyTime 36.317 units on a scaleStandard Error 0.288
Routine Care Control GroupAnxietyTime 28.175 units on a scaleStandard Error 0.272
Comparison: IBM SPSS Statistics 20 was used to perform the statistical analysis. A mixed model for repeated measures was used to examine the differences between the three groups over time for the primary outcome, anxiety. All models were estimated by the method of restricted maximum likelihood (REML) and the Compound Symmetry covariance structure was chosen for the repeated measures. The analysiswas performed according to the intention to treat.p-value: <0.05Mixed Models Analysis
Comparison: To test the difference in psychological well-being between three groups with a power of 95%,a ¼ 0.05 and a medium effect size ( f ¼ 0.25), a total of 297 participants were required (99 patients per group). Taking into account a 20% attrition rate, at least 124 women had to be recruited in each group.p-value: <0.05Mixed Models Analysis
Secondary

Depression

The Hospital Anxiety and Depression Scale (HADS) was used to measure general anxiety and depression (Zigmond and Snaith, 1983). TheHADSconsists of 14 items (7 items for each subscale) that are rated on a 4-point Likert scale. The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0 to 21). Scores on each scale can be interpreted in ranges: normal (0-7), mild (8-10), moderate (11-14) and severe (15-21) anxiety and depression.

Time frame: T1 during the first week of the stimulation phase, T2 on the 10th day after embryo transfer, T3 six weeks after embryo transfer

Population: Only in women with embryo transfer

ArmMeasureGroupValue (MEAN)Dispersion
PRCI-monitoring GroupDepressionTime 33.983 units on a scaleStandard Error 0.23
PRCI-monitoring GroupDepressionTime 23.709 units on a scaleStandard Error 0.222
PRCI-monitoring GroupDepressionTime 13.389 units on a scaleStandard Error 0.199
Monitoring-control GroupDepressionTime 13.391 units on a scaleStandard Error 0.201
Monitoring-control GroupDepressionTime 33.708 units on a scaleStandard Error 0.216
Monitoring-control GroupDepressionTime 23.676 units on a scaleStandard Error 0.206
Routine Care Control GroupDepressionTime 33.736 units on a scaleStandard Error 0.238
Routine Care Control GroupDepressionTime 24.224 units on a scaleStandard Error 0.225
Routine Care Control GroupDepressionTime 13.269 units on a scaleStandard Error 0.208
Comparison: IBM SPSS Statistics 20 was used to perform the statistical analysis. A mixed model for repeated measures was used to examine the differences between the three groups over time for the secondary outcome, depression. All models were estimated by the method of restricted maximum likelihood (REML) and the Compound Symmetry covariance structure was chosen for the repeated measures. The analysiswas performed according to the intention to treat.p-value: <0.05Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026